Impact of maternal stress and poly(i:c)-stimulated viral activation on placental immune dynamics and offspring neurobehavioral development

Active Project Grant Awarded Last action

Award ID
F30HD117624
Recipient
Awarding agency
Obligated
$177,769

Award facts

Completion date 28% complete
Place of performance
Columbus, OH 43210, USA

Award details come from USAspending.gov.

About this award

The National Institute of Child Health and Human Development awarded The Ohio State University $177,769 on October 15, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the impact of maternal stress and poly(I:C)-stimulated viral activation on placental immune dynamics and offspring neurobehavioral development.

The research applies an established prenatal stress and viral-mimetic exposure model to transgenic mice expressing tdTomato in fetal macrophages. Aim 1 involves investigating changes in the placental immune response using flow cytometry, immunohistochemistry, and RNA-sequencing of fluorescence-activated cell sorted maternal and fetal macrophages. The work builds on preliminary findings showing that prenatal stress increases fetal microglia inflammatory cytokine expression persisting into adulthood, reduces maternal macrophage presence in the placenta relative to fetal-derived macrophages, and suppresses maternal plasma cytokine response to viral stimulation. The project hypothesizes that prenatal stress impairs placental immune response to maternal viral stimulation, potentiating effects of maternal immune activation on fetal neuroimmune and behavioral development—mechanisms potentially shared across autism spectrum disorder and schizophrenia.

Performance runs through June 30, 2029, at Columbus, Ohio. This is a Project Grant, a standard research assistance type under the NICHD extramural research portfolio.

Description

Abstract
The etiology of neurodevelopmental psychiatric disorders such as autism spectrum disorder (ASD) and schizophrenia remains elusive, hindering the innovation of novel treatments. These disorders are thought to have an overlap in their pathophysiology due to a shared association with in utero exposure to maternal infection, stress, and cytokine levels. These hypothesized immune programming mechanisms have begun to be investigated by using mouse models of prenatal stress and maternal immune activation which cause a similar offspring behavioral phenotype as these disorders. Our lab has established prenatal stress to increase fetal microglia inflammatory cytokine expression, which continues into adulthood in the cortex, suggesting their function is dysregulated throughout life. Further, preliminary data from our lab has shown prenatal stress to reduce the presence of maternal macrophages relative to fetal-derived macrophages in the placenta with an overall decrease in immune cells. This imbalance is paralleled by a diminished interferon response and a stressed-induced suppression in the maternal plasma cytokine response to exposure of the viral mimetic poly(i:c). Given this preliminary data, we hypothesize that prenatal stress impairs the placental immune response to maternal viral stimulation with a subsequent potentiation of the effects of maternal immune activation on fetal neuroimmune and behavioral development. To delineate the specific effects on maternal and fetal placental immune cells we will apply our established prenatal stress and poly(i:c) exposure model to a transgenic mouse line that specifically expresses tdtomato in fetal macrophages. In aim 1, we will investigate changes in the placental immune response using flow cytometry, immunohistochemistry, and RNA-sequencing of facs sorted maternal and fetal macrophages. In aim 2, we will assess the changes in fetal microglia using RNA-sequencing and evaluate their long-term programming by isolating microglia from adult wild type offspring to evaluate their reactivity in vitro. Further, we will characterize changes to offspring communicative output, social behavior, anxiety-like behavior, and repetitive behaviors to determine whether the interaction between prenatal stress and maternal viral stimulation potentiate the deleterious behavioral consequences on the offspring. Our approach is innovative and significant, as IT will be the first project to define the maternal and fetal specific effects on placental immune function in both prenatal stress and poly(i:c) stimulation and how these common maternal environmental disruptions interact to impact offspring neuroimmune and behavioral development. The outlined aims are coupled with a rigorous training plan integrating advanced technical skill development in in vivo analyses, high-parameter flow cytometry, and bioinformatics with essential non-technical skill development in scientific communication, mentorship, and scientific writing. This comprehensive training plan will provide the unique and necessary skills to develop into an independent physician-scientist innovating novel therapies for neurodevelopmental disorders.

Transactions

Action Obligated Date
Amendment $45,547
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $44,074
Amendment $44,074
Original award $44,074

Quick answers

Who received award F30HD117624?

F30HD117624 was awarded to The Ohio State University by National Institute of Child Health and Human Development (National Institutes of Health) on October 15, 2025.

How much is award F30HD117624 worth?

$177,769 has been obligated on F30HD117624.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award